GrinnWeb
GrinnWeb is a bioinformatics platform contains a graph database, an R package and web application for metabolomics studies. It aims to broaden metabolomics studies by allowing mapping of omics data such as genomics, transcriptomics, proteomics and metabolomics for a systems level exploration.
Features
- There are three main functions. See each page for more information
1) SEARCH - query for metabolites, proteins, genes and metabolic pathways
2) BUILD - connect given metabolites based on several kinds of relationships
3) PAIR - generate an integrated network of metabolites, proteins, genes and pathways - Use KEGG as a main resource to derive connections between the molecular components.
- Generate two types of networks: a network of connected metabolites and an integrated network of metabolites, proteins, genes and pathways.
- Link metabolites with four relationship types: biochemical reaction, enzyme catalysis, encoding gene and metabolic pathway.
- Connect metabolites to three element types:protein, gene and pathway.
- Provide interactive network visualization and easily export results and style for Cytoscape.
Online usage
- For online usage under UC Davis network, click here
Local running
- For local usage, install grinnWeb R package from github
install.packages("devtools")
library(devtools)
install_github("kwanjeeraw/grinnWeb")
- Download and then unzip Neo4j server
- Extract and move the grinn database files to the Neo4j server directory
- Start the Neo4j server, for windows: Double-click on %NEO4J_HOME%\bin\Neo4j.bat, for linux: ./bin/neo4j start for more details see here
library(grinnWeb)
library(opencpu)
opencpu$browse("library/grinnWeb/www")
References
Metabolomics and transcriptomics data used in our examples are taken from the following publication:
- April W, et al. Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis. F1000Res. 2014;3:248.
- Rosenberg A, et al. Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy. PLoS One. 2014;9(10).